Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPR3 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | RPS6KA4 | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
mRNA | PRSS8 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | SLC6A14 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | PDGFB | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
mRNA | STX2 | CCLE | pan-cancer | AAC | -0.21 | 4e-05 |
mRNA | TXNDC8 | CCLE | pan-cancer | AAC | -0.19 | 5e-05 |
mRNA | CLGN | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | PHC2 | CCLE | pan-cancer | AAC | -0.21 | 5e-05 |
mRNA | ADGRF4 | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |